-
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Given Average Rating of "Buy" by Analysts
Source: Buzz FX / 21 Jan 2025 01:21:18 America/Chicago
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Given Average Rating of "Buy" by Analysts Written by MarketBeat January 21, 2025 Share Link copied to clipboard. Shares of Zevra Therapeutics, Inc. ( NASDAQ:ZVRA - Get Free Report ) have been given a c
Read more...